Skip to content

Medical-device intelligence

Randox Laboratories, Limited: FDA clearances and recalls

Research Randox Laboratories, Limited in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

18 clearance records and 13 recall records in the covered releases, across 1 source company names and 13 product codes. Dated history runs from Sep 9, 2004 to Jan 23, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202610
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

31 matching records
Device / recordCompany in FDA recordSourceSource date
Evidence MultiSTAT DOA Urine MultiPlexK250741 · DJGRandox Laboratories Limited510(k)Jan 23, 2026FDA decision date
Randox Lipoprotein (a) - In vitro diagnostic (IVD) use as Randox Lipoprotein (a) assay on automated analysers. Catalog Number: LP3403Z-1017-2025 · DFCRandox Laboratories, LimitedRecallJan 23, 2025FDA classification date
Randox Lipoprotein (a) - In vitro diagnostic (IVD) use as Randox Lipoprotein (a) assay on automated analysers. Catalog Number: LP2757Z-1018-2025 · DFCRandox Laboratories, LimitedRecallJan 23, 2025FDA classification date
Evidence MultiSTAT DOA Urine MultiPlex, Evidence MultiSTATK220451 · DJGRandox Laboratories Limited510(k)Oct 5, 2023FDA decision date
Evidence MultiSTAT DOA Urine MultiPlexK221550 · DJGRandox Laboratories Limited510(k)Oct 5, 2023FDA decision date
RX Daytona Plus (with ISE/without ISE); Models Nos. RX4040 (w/ISE) and RX4041 (without ISE) - Product Usage: A fully automated, random access, cl…Z-1349-2020 · JJERandox Laboratories, LimitedRecallFeb 24, 2020FDA classification date
Randox Liquid Cardiac Controls Catalogue Number CQ5051Z-0412-2020 · JJYRandox Laboratories, LimitedRecallNov 15, 2019FDA record creation date
Randox Liquid Cardiac Controls Catalogue Number CQ5052.Z-0413-2020 · JJYRandox Laboratories, LimitedRecallNov 15, 2019FDA record creation date
Randox Liquid Cardiac Controls Catalogue Numbers CQ5053.Z-0414-2020 · JJYRandox Laboratories, LimitedRecallNov 15, 2019FDA record creation date
RANDOX NEFA (Non-Esterified Fatty Acids) FA115 Lot 485343, GTIN: 5055273203066.Z-0367-2020 · JLGRandox Laboratories, LimitedRecallNov 13, 2019FDA record creation date
Assayed Bovine Multi-Sera Level 1, Model No. AL1027Z-2207-2019 · JJYRandox Laboratories, LimitedRecallAug 7, 2019FDA record creation date
Human Assayed Multi-Sera Level 2, Model NO. HN1530 Product Usage: This product is intended for in vitro diagnostic use, in the quality control …Z-2150-2019 · JJYRandox Laboratories, LimitedRecallAug 6, 2019FDA record creation date
RX Daytona, Model Nos. RX4040 and RX4041Z-2083-2019 · JJERandox Laboratories, LimitedRecallJul 25, 2019FDA record creation date
RX Imola, Model Nos. RX4900Z-2084-2019 · JJERandox Laboratories, LimitedRecallJul 25, 2019FDA record creation date
Liquid Cardiac Control CQ5053Z-0937-2018 · JJYRandox Laboratories, LimitedRecallMar 9, 2018FDA record creation date
Randox RX Daytona Plus Alkaline Phosphatase (ALP)K162275 · CJERandox Laboratories Limited510(k)Apr 21, 2017FDA decision date
Direct LDL Cholesterol (LDL)K161691 · MRRRandox Laboratories Limited510(k)Mar 20, 2017FDA decision date
Magnesium on RX Imola analyser IVDZ-0725-2017 · JGJRandox Laboratories, LimitedRecallDec 8, 2016FDA record creation date
Direct BilirubinK152343 · JFMRandox Laboratories Limited510(k)Feb 16, 2016FDA decision date
Total BilirubinK152344 · JFMRandox Laboratories Limited510(k)Jan 28, 2016FDA decision date
TriglyceridesK150819 · CDTRandox Laboratories Limited510(k)Aug 6, 2015FDA decision date
LIQUID ASSAYED CHEMISTRY CONTROL PREMIUM PLUS LEVEL 1,2 AND LEVEL 3.K140971 · JJYRandox Laboratories Limited510(k)Dec 8, 2014FDA decision date
RANDOX ALDOLASE CALIBRATION SERUMK142181 · JITRandox Laboratories Limited510(k)Sep 18, 2014FDA decision date
RANDOX IMMUNOASSAY PREMIUM PLUS CONTROL LEVELS 1,2 AND LEVEL 3 AND IMMUNOASSAY PREMIUM PLUS TRI-LEVEL CONTROLK140522 · JJYRandox Laboratories Limited510(k)May 22, 2014FDA decision date
RANDOX AMMONIA ETHANOL CONTROL LEVELS 1, 2 AND LEVEL 3K140393 · JJYRandox Laboratories Limited510(k)Mar 25, 2014FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗